Immunome, Inc.
IMNM
$18.08
-$0.32-1.71%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 22.98% | -21.66% | -32.40% | -4.22% | 48.11% |
| Total Depreciation and Amortization | -2.96% | 5.87% | 1.81% | -0.83% | 22.02% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -55.25% | 205.19% | 16.85% | 3.03% | -84.88% |
| Change in Net Operating Assets | -521.47% | -68.81% | 187.89% | 30.95% | -421.97% |
| Cash from Operations | -22.28% | -18.37% | 18.00% | 6.89% | -26.14% |
| Capital Expenditure | 24.93% | -258.33% | -23.31% | 75.31% | -225.49% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | 297.58% | -822.71% | -19.57% |
| Cash from Investing | -200.48% | -103.23% | 293.05% | -1,360.97% | -47.85% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.95% | 894.59% | 21,438.60% | -99.88% | 743.12% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 98.69% | -2,923.07% | -240.37% | 97.42% | -2,521.25% |
| Cash from Financing | -100.03% | 853.52% | 82,625.45% | -100.03% | 707.71% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -118.59% | 195.77% | 213.32% | -199.44% | 1,035.27% |